TMA indicated that RIP1 expression is upregulated in CRC primary cancer tissues, and that the levels of RIP1 and β-catenin are higher in metastatic tissues of CRC patients than in their CRC primary cancer tissues (Fig. 1D, E). The gene discussed is RIPK1; the disease is colorectal carcinoma.